Cite
HARVARD Citation
Iriyama, N. et al. (n.d.). Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D‐first study. American journal of hematology. 90 (9), pp. 819-824. [Online].